Cited by 530Menopause: Health Impacts and TreatmentsOvarian function and disordersEstrogen and related hormone effects

Hormonal changes in the menopause transition

Open access
Burger, H. G.·2002·Recent Progress in Hormone Research

Abstract

The menopause is the permanent cessation of menstruation resulting from the loss of ovarian follicular activity. It is heralded by the menopausal transition, a period when the endocrine, biological, and clinical features of approaching menopause begin. A common initial marker is the onset of menstrual irregularity. The biology underlying the transition to menopause includes central neuroendocrine changes as well as changes within the ovary, the most striking of which is a profound decline in follicle numbers. Follicle-stimulating hormone (FSH) is an established indirect marker of follicular activity. In studies of groups of women, its concentration, particularly in the early follicular phase of the menstrual cycle, begins to increase some years before there are any clinical indications of approaching menopause. The rise in FSH is the result of declining levels of inhibin B (INH-B), a dimeric protein that reflects the fall in ovarian follicle numbers, with or without any change in the ability of the lining granulosa cells to secrete INH-B. Estradiol levels remain relatively unchanged or tend to rise with age until the onset of the transition and are usually well preserved until the late perimenopause, presumably in response to the elevated FSH levels. During the transition, hormone levels frequently vary markedly - hence, measures of FSH and estradiol are unreliable guides to menopausal status. Concentrations of testosterone have been reported to fall by about 50% during reproductive life, between the ages of 20 and 40. They change little during the transition and, after menopause, may even rise. Dehydroepiandrosterone (DHEA) and DHEAS, its sulphate, on the other hand, decline with age, without any specific influence of the menopause. Symptoms of the menopause can be interpreted as resulting primarily from the profound fall in estradiol, occurring over a 3- to 4-year period around final menses, a fall that presumably contributes importantly to the beginning, in the late perimenopause, of loss of bone mineral density.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/rp.57.1.257

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Burger, H. G.
Affiliations
Monash Medical Centre (AU)
Corresponding author
Burger, H. G.
Venue
Recent Progress in Hormone Research
Published
2002-01-01
Volume
57
Issue
1
Pages
257-275
ISSN
0079-9963 (ISSN-L)
OpenAlex
W2124569831
Cited by
530
References
27
Citations by year
2026: 27 · 2025: 48 · 2024: 25 · 2023: 31 · 2022: 29 · 2021: 13 · 2020: 15 · 2019: 13 · 2018: 17 · 2017: 20 · 2016: 20 · 2015: 23 · 2014: 24 · 2013: 21 · 2012: 24
FWCI
7.98
Type
journal article
Language
en
Open access
Locations
  • Recent Progress in Hormone Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Oxford Brookes University
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
menopause, perimenopause, follicle-stimulating hormone, inhibin B, estradiol, testosterone, dehydroepiandrosterone, dehydroepiandrosterone sulfate, menstrual irregularity, bone mineral loss, neuroendocrine changes
MeSH terms
Adult, Aging, Androgens, Estradiol, Female, Follicle Stimulating Hormone, Hormones, Humans, Inhibins, Menopause, Middle Aged, Ovary, Pituitary Gland, Progesterone, World Health Organization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review